Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2013

Open Access 01-12-2013 | Research

The association and predictive value analysis of metabolic syndrome combined with resting heart rate on cardiovascular autonomic neuropathy in the general Chinese population

Authors: Yu Lu, Zi-Hui Tang, Fangfang Zeng, Yiming Li, Linuo Zhou

Published in: Diabetology & Metabolic Syndrome | Issue 1/2013

Login to get access

Abstract

Background

The purpose of this study was to explore the extent of associations of cardiovascular autonomic neuropathy (CAN) with metabolic syndrome (MetS) and resting heart reate (HR), and to evaluate the predictive value of MetS combined with HR on CAN in a large sample derived from a Chinese population.

Materials and methods

We conducted a large-scale, population-based, cross-sectional study to explore the relationships of CAN with MetS and resting HR. This study included 2092 participants aged 30–80 years, and a total of 387 subjects were diagnosed with CAN in our dataset. The associations of CAN with MetS and resting HR were assessed by a multivariate logistic regression (MLR) analysis (using subjects without CAN as a reference group) after controlling for potential confounding factors. The predictive performance of resting HR and MetS was evaluated using the area under the receiver-operating characteristic curve (AUC).

Results

A tendency toward increased CAN prevalence with increasing resting HR was reported (p for trend < 0.001). MLR analysis showed that MetS and resting HR were very significantly and independently associated with CAN (β = 0.495 for MetS and β = 0.952 for HR, P < 0.001 for both). Resting HR alone and combined with MetS (MetS-HR) strongly predicted CAN (AUC = 0.719, P < 0.001 for resting HR and AUC = 0.735, P < 0.001 for MetS-HR).

Conclusion

Our findings signify that MetS and resting HR were very significantly and independently associated with CAN in the general Chinese population. Resting HR and MetS-HR both have a high value in predicting CAN in the general population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hazari MA, Khan RT, Reddy BR, et al: Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences (Riyadh). 2012, 17: 173-175. Hazari MA, Khan RT, Reddy BR, et al: Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences (Riyadh). 2012, 17: 173-175.
2.
go back to reference Kuehl M, Stevens MJ: Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012, 8: 405-416. 10.1038/nrendo.2012.21.CrossRefPubMed Kuehl M, Stevens MJ: Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012, 8: 405-416. 10.1038/nrendo.2012.21.CrossRefPubMed
3.
go back to reference Spallone V, Ziegler D, Freeman R, et al: Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011, [Epub ahead of print] Spallone V, Ziegler D, Freeman R, et al: Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011, [Epub ahead of print]
4.
go back to reference Garruti G, Giampetruzzi F, Vita MG, et al: Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res. 2012, 2012: 615835-PubMedCentralCrossRefPubMed Garruti G, Giampetruzzi F, Vita MG, et al: Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res. 2012, 2012: 615835-PubMedCentralCrossRefPubMed
5.
go back to reference Laitinen T, Lindstrom J, Eriksson J, et al: Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabet Med. 2011, 28: 699-704. 10.1111/j.1464-5491.2011.03278.x.CrossRefPubMed Laitinen T, Lindstrom J, Eriksson J, et al: Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabet Med. 2011, 28: 699-704. 10.1111/j.1464-5491.2011.03278.x.CrossRefPubMed
6.
go back to reference Iodice V, Low DA, Vichayanrat E, et al: Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci. 2011, 310: 133-138. 10.1016/j.jns.2011.07.014.CrossRefPubMed Iodice V, Low DA, Vichayanrat E, et al: Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci. 2011, 310: 133-138. 10.1016/j.jns.2011.07.014.CrossRefPubMed
7.
go back to reference Ziegler D, Zentai C, Perz S, et al: Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006, 114: 153-159. 10.1055/s-2006-924083.CrossRefPubMed Ziegler D, Zentai C, Perz S, et al: Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006, 114: 153-159. 10.1055/s-2006-924083.CrossRefPubMed
8.
go back to reference Kamphuis MH, Geerlings MI, Dekker JM, et al: Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil. 2007, 14: 796-802. 10.1097/HJR.0b013e32829c7d0c.CrossRefPubMed Kamphuis MH, Geerlings MI, Dekker JM, et al: Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil. 2007, 14: 796-802. 10.1097/HJR.0b013e32829c7d0c.CrossRefPubMed
9.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288: 2709-2716. 10.1001/jama.288.21.2709.CrossRefPubMed
10.
go back to reference Aurigemma GP, Gaasch WH: Clinical practice. Diastolic heart failure. N Engl J Med. 2004, 351: 1097-1105. 10.1056/NEJMcp022709.CrossRefPubMed Aurigemma GP, Gaasch WH: Clinical practice. Diastolic heart failure. N Engl J Med. 2004, 351: 1097-1105. 10.1056/NEJMcp022709.CrossRefPubMed
11.
go back to reference Maser RE, Lenhard MJ: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005, 90: 5896-5903. 10.1210/jc.2005-0754.CrossRefPubMed Maser RE, Lenhard MJ: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005, 90: 5896-5903. 10.1210/jc.2005-0754.CrossRefPubMed
12.
go back to reference Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115: 387-397. 10.1161/CIRCULATIONAHA.106.634949.CrossRefPubMed Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115: 387-397. 10.1161/CIRCULATIONAHA.106.634949.CrossRefPubMed
13.
go back to reference Rasic-Milutinovic ZR, Milicevic DR, Milovanovic BD, et al: Do components of metabolic syndrome contribute to cardiac autonomic neuropathy in non-diabetic patients?. Saudi Med J. 2010, 31: 650-657.PubMed Rasic-Milutinovic ZR, Milicevic DR, Milovanovic BD, et al: Do components of metabolic syndrome contribute to cardiac autonomic neuropathy in non-diabetic patients?. Saudi Med J. 2010, 31: 650-657.PubMed
14.
go back to reference Chang CJ, Yang YC, Lu FH, et al: Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med. 2010, 123: 432-438. 10.1016/j.amjmed.2009.07.031.CrossRefPubMed Chang CJ, Yang YC, Lu FH, et al: Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med. 2010, 123: 432-438. 10.1016/j.amjmed.2009.07.031.CrossRefPubMed
15.
go back to reference Li Z, Tang ZH, Zeng F, et al: Associations between the severity of metabolic syndrome and cardiovascular autonomic function in a Chinese population. J Endocrinol Invest. 2013, [Epub ahead of print] Li Z, Tang ZH, Zeng F, et al: Associations between the severity of metabolic syndrome and cardiovascular autonomic function in a Chinese population. J Endocrinol Invest. 2013, [Epub ahead of print]
16.
go back to reference Pickering TG, Hall JE, Appel LJ, et al: Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005, 7: 102-109. 10.1111/j.1524-6175.2005.04377.x.CrossRef Pickering TG, Hall JE, Appel LJ, et al: Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich). 2005, 7: 102-109. 10.1111/j.1524-6175.2005.04377.x.CrossRef
17.
go back to reference Grundy SM, Hansen B, Smith SC, et al: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004, 109: 551-556. 10.1161/01.CIR.0000112379.88385.67.CrossRefPubMed Grundy SM, Hansen B, Smith SC, et al: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004, 109: 551-556. 10.1161/01.CIR.0000112379.88385.67.CrossRefPubMed
18.
go back to reference Boudina S, Abel ED: Diabetic cardiomyopathy revisited. Circulation. 2007, 115: 3213-3223. 10.1161/CIRCULATIONAHA.106.679597.CrossRefPubMed Boudina S, Abel ED: Diabetic cardiomyopathy revisited. Circulation. 2007, 115: 3213-3223. 10.1161/CIRCULATIONAHA.106.679597.CrossRefPubMed
19.
go back to reference Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005, 54: 1615-1625. 10.2337/diabetes.54.6.1615.CrossRefPubMed Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005, 54: 1615-1625. 10.2337/diabetes.54.6.1615.CrossRefPubMed
20.
go back to reference Ouwens DM, Diamant M: Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem. 2007, 113: 76-86. 10.1080/13813450701422633.CrossRefPubMed Ouwens DM, Diamant M: Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy. Arch Physiol Biochem. 2007, 113: 76-86. 10.1080/13813450701422633.CrossRefPubMed
21.
go back to reference Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006, 440: 944-948. 10.1038/nature04634.CrossRefPubMed Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006, 440: 944-948. 10.1038/nature04634.CrossRefPubMed
22.
go back to reference Palmieri V, Russo C, Bella JN: Treatment of isolated left ventricular diastolic dysfunction in hypertension: reaching blood pressure target matters. Hypertension. 2010, 55: 224-225. 10.1161/HYPERTENSIONAHA.109.144717.CrossRefPubMed Palmieri V, Russo C, Bella JN: Treatment of isolated left ventricular diastolic dysfunction in hypertension: reaching blood pressure target matters. Hypertension. 2010, 55: 224-225. 10.1161/HYPERTENSIONAHA.109.144717.CrossRefPubMed
23.
go back to reference Owan TE, Hodge DO, Herges RM, et al: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355: 251-259. 10.1056/NEJMoa052256.CrossRefPubMed Owan TE, Hodge DO, Herges RM, et al: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355: 251-259. 10.1056/NEJMoa052256.CrossRefPubMed
24.
go back to reference Widlansky ME, Gokce N, Keaney JF, et al: The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003, 42: 1149-1160. 10.1016/S0735-1097(03)00994-X.CrossRefPubMed Widlansky ME, Gokce N, Keaney JF, et al: The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003, 42: 1149-1160. 10.1016/S0735-1097(03)00994-X.CrossRefPubMed
Metadata
Title
The association and predictive value analysis of metabolic syndrome combined with resting heart rate on cardiovascular autonomic neuropathy in the general Chinese population
Authors
Yu Lu
Zi-Hui Tang
Fangfang Zeng
Yiming Li
Linuo Zhou
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2013
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-5-73

Other articles of this Issue 1/2013

Diabetology & Metabolic Syndrome 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine